Age related macular degeneration 9: genes and variants
Explore variant evidence for Age related macular degeneration 9 across 7 analyzed proteins (ABCA4, CFH, APOE, C3, CETP and 2 more). Linked ClinVar records include 44 pathogenic or likely pathogenic variants, 143 variants of uncertain significance and 30 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Age related macular degeneration 9
ABCA4: Retinal-specific phospholipid-transporting ATPase ABCA4
It flips retinal-derived lipid adducts across photoreceptor disc membranes so they can be cleared during the visual cycle. Biallelic loss-of-function variants cause Stargardt disease and can also produce cone-rod dystrophy or retinitis pigmentosa.
41 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in ABCA4 have source records linked to Age related macular degeneration 9. Association strength is not clinical gene validity.
CFH: Complement factor H
It restrains the alternative complement pathway on host surfaces and in plasma, protecting tissues from uncontrolled complement amplification. Pathogenic variants or risk alleles are associated with atypical hemolytic uremic syndrome, C3 glomerulopathy, and age-related macular degeneration.
2 ClinVar pathogenic / likely pathogenic and 10 uncertain variants in CFH have source records linked to Age related macular degeneration 9. Association strength is not clinical gene validity.
APOE: Apolipoprotein E
It redistributes cholesterol and other lipids between tissues by directing remnant lipoproteins to LDL-receptor-family members. The common epsilon4 isoform strongly increases late-onset Alzheimer disease risk and also influences plasma lipids and cardiovascular risk.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in APOE have source records linked to Age related macular degeneration 9. Association strength is not clinical gene validity.
C3: Complement C3
It is cleaved during complement activation to generate C3a and C3b, which amplify inflammation, opsonize targets, and drive formation of downstream complement complexes. Deficiency causes severe susceptibility to bacterial infection, while dysregulated activation contributes to complement-mediated kidney and inflammatory diseases.
0 ClinVar pathogenic / likely pathogenic and 142 uncertain variants in C3 have source records linked to Age related macular degeneration 9. Association strength is not clinical gene validity.
CETP: Cholesteryl ester transfer protein
It transfers cholesteryl esters and triglycerides between HDL and apoB-containing lipoproteins, strongly influencing circulating lipoprotein composition. Loss-of-function variants can raise HDL cholesterol, while pharmacologic CETP inhibition has been developed to lower atherosclerotic cardiovascular risk.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CETP have source records linked to Age related macular degeneration 9. Association strength is not clinical gene validity.
FBN2: Fibrillin-2
It contributes to extracellular microfibrils that guide elastic-fiber formation and tissue organization during development. Heterozygous pathogenic variants cause congenital contractural arachnodactyly, characterized by long limbs and fingers, contractures, and characteristic ear abnormalities.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FBN2 have source records linked to Age related macular degeneration 9. Association strength is not clinical gene validity.
LIPC: Hepatic triacylglycerol lipase
It hydrolyzes triglycerides and phospholipids in HDL and remnant particles at the liver surface, helping remodel circulating lipoproteins. Loss-of-function variants can raise HDL cholesterol and alter remnant metabolism, with variable effects on atherosclerotic risk.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in LIPC have source records linked to Age related macular degeneration 9. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Age related macular degeneration 9
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ABCA4 C1488F | 1488 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 G65E | 65 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 D576H | 576 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 T971N | 971 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 T1019A | 1019 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 G1091E | 1091 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 C1488R | 1488 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 K1978E | 1978 | ABC transporter 2 | Pathogenic / likely pathogenic (★★) |
| ABCA4 L2060R | 2060 | ABC transporter 2 | Pathogenic / likely pathogenic (★★) |
| ABCA4 T972N | 972 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 S1071L | 1071 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 D1102Y | 1102 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1129H | 1129 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1640W | 1640 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 I1846T | 1846 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 E2131K | 2131 | ABC transporter 2 | Pathogenic / likely pathogenic (★★) |
| ABCA4 P143L | 143 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 E328V | 328 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1640Q | 1640 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 L1784P | 1784 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 F2188S | 2188 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ABCA4 R24C | 24 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 C230S | 230 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 D645N | 645 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 W821R | 821 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1443C | 1443 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 L1729P | 1729 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 Y1858N | 1858 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 T1981R | 1981 | ABC transporter 2 | Pathogenic / likely pathogenic (★★) |
| ABCA4 T2240A | 2240 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ABCA4 N96D | 96 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 G991V | 991 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 E1036K | 1036 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 G1050D | 1050 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 D1532N | 1532 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 A1598D | 1598 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 A1881V | 1881 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 R220C | 220 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 P309R | 309 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 M448V | 448 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1860W | 1860 | Extracellular | Pathogenic / likely pathogenic (★★) |
| APOE R43C | 43 | Pathogenic / likely pathogenic (★★) | |
| CFH C431S | 431 | Sushi 7 | Pathogenic / likely pathogenic (★) |
| CFH C325Y | 325 | Sushi 6 | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Age related macular degeneration 9
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 93 out of 100
- MetaLR: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 92 out of 100
- MutPred: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 90 out of 100
- phyloP: 89 out of 100
- PolyPhen-2: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 84 out of 100
- Pangolin: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Severe early-childhood-onset retinal dystrophy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Age related macular degeneration 9 variants (148 pathogenic / likely pathogenic).
- ABCA4-related retinopathy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Age related macular degeneration 9 variants (60 pathogenic / likely pathogenic).
- Retinitis pigmentosa also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Age related macular degeneration 9 variants (58 pathogenic / likely pathogenic).
- Stargardt disease also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Age related macular degeneration 9 variants (41 pathogenic / likely pathogenic).
- Cone-rod dystrophy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Age related macular degeneration 9 variants (29 pathogenic / likely pathogenic).
- Atypical hemolytic-uremic syndrome also has ClinVar records linked to CFH variants; they fall mostly in different places as the Age related macular degeneration 9 variants (12 pathogenic / likely pathogenic).
- Factor H deficiency also has ClinVar records linked to CFH variants; they fall mostly in different places as the Age related macular degeneration 9 variants (4 pathogenic / likely pathogenic).
- Familial type 3 hyperlipoproteinemia also has ClinVar records linked to APOE variants; they fall mostly in different places as the Age related macular degeneration 9 variants (10 pathogenic / likely pathogenic).
- Familial hypercholesterolemia also has ClinVar records linked to APOE variants; they fall mostly in different places as the Age related macular degeneration 9 variants (3 pathogenic / likely pathogenic).
Diseases related to Age related macular degeneration 9
- Retinal disorder, also linked to ABCA4, C3, CETP and CFH
- Type 2 diabetes mellitus, also linked to APOE and LIPC
- Atypical hemolytic-uremic syndrome, also linked to C3 and CFH
- Familial hypercholesterolemia, also linked to APOE
- Familial thoracic aortic aneurysm and aortic dissection, also linked to FBN2
- Retinitis pigmentosa, also linked to ABCA4
- Leber congenital amaurosis, also linked to ABCA4
- Severe early-childhood-onset retinal dystrophy, also linked to ABCA4
- Alzheimer disease, also linked to APOE
- Cone-rod dystrophy, also linked to ABCA4
- ABCA4-related retinopathy, also linked to ABCA4
- Stargardt disease, also linked to ABCA4
Frequently asked questions
Which genes have records linked to Age related macular degeneration 9?
This view contains 7 analyzed proteins: ABCA4, CFH, APOE, C3, CETP and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 44 pathogenic or likely pathogenic variants, 143 variants of uncertain significance and 30 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 234 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center